Form 4: GoodRx Holdings Chairman Trevor Bezdek Reports Stock Transactions
SEC Form 4
Trevor Bezdek, Chairman of GoodRx Holdings, reports the vesting and conversion of restricted stock units and Class B common stock into Class A common stock, along with a disposition of shares to cover tax obligations.
Summary
- On September 1, 2024, Trevor Bezdek, Chairman of GoodRx Holdings, engaged in several transactions involving the company's stock.
- These transactions included the vesting of 256,595 restricted stock units, which converted into Class B common stock.
- Subsequently, these Class B shares were converted into Class A common stock.
- A portion of the Class B common stock, specifically 130,043 shares, was disposed of to cover tax obligations at a price of $7.9 per share.
- Additionally, 126,552 Class B shares were converted into Class A common stock.
- Following these transactions, Bezdek directly owns 126,552 shares of Class A Common Stock.
- Bezdek also indirectly owns 2,632,721 shares of Class A Common Stock through TB 2024 GRAT and 2,632,721 shares through JB 2024 GRAT.
- The reporting person disclaims beneficial ownership of shares held by JB 2024 GRAT.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects. The transactions themselves (vesting, conversion, and tax-related sales) are common occurrences.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the buying and selling activities of key personnel, which can be an indicator of their confidence in the company's prospects.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US.
- Similar filings are made by insiders at companies like CVS Health, Walgreens Boots Alliance, and Amazon, providing insights into their executives' stock transactions.
- The details disclosed, such as the number of shares, transaction prices, and dates, are consistent with the level of information required by the SEC for insider trading reporting.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
- The tax-related sale of shares could slightly dilute the stock's value.
Key Dates
| Date | Description |
|---|---|
| 09/01/2020 | Commencement date of the 16 equal quarterly installments for vesting of restricted stock units. |
| 09/01/2024 | Date of the reported transactions: vesting of restricted stock units, conversion of Class B to Class A common stock, and disposition of shares for tax obligations. |
| 09/03/2024 | Date of signature for the Form 4 filing. |
| 09/25/2027 | Date upon which each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.